| Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: alleviating effect of palmatine I Kiris, W Kukula-Koch, M Karayel-Basar, B Gurel, J Coskun, AT Baykal Biomedicine & Pharmacotherapy 158, 114111, 2023 | 14 | 2023 |
| Evaluation of the therapeutic effect of lycoramine on Alzheimer’s disease in mouse model I Kiris, MK Basar, B Sahin, B Gurel, J Coskun, T Mroczek, AT Baykal Current medicinal chemistry 28 (17), 3449-3473, 2021 | 10 | 2021 |
| Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity MA Altinoz, Y Ucal, MC Yilmaz, İ Kiris, O Ozisik, U Sezerman, A Ozpinar, ... Cancer Medicine 9 (16), 5767-5780, 2020 | 10 | 2020 |
| Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer’s disease patients S Koca, I Kiris, S Sahin, N Cinar, S Karsidag, HA Hanagasi, GB Yildiz, ... Neuroscience Letters 786, 136799, 2022 | 9 | 2022 |
| Molecular effects of pteryxin and scopoletin in the 5xFAD Alzheimer’s disease mouse model I Kiris, K Skalicka-Wozniak, MK Basar, B Sahin, B Gurel, AT Baykal Current Medicinal Chemistry 29 (16), 2937-2950, 2022 | 9 | 2022 |
| Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain M Karayel-Basar, I Uras, I Kiris, B Sahin, E Akgun, AT Baykal Molecular omics 18 (4), 336-347, 2022 | 6 | 2022 |
| O-demethyl galantamine alters protein expression in cerebellum of 5xFAD mice İ Kiriş, M KARAYEL BAŞAR, B Gurel, T Mroczek, AT Baykal Turkish Journal of Biology 48 (3), 163-173, 2024 | | 2024 |
| Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix‐assisted laser desorption/ionization mass spectrometry (MALDI‐MS) imaging M Karayel‐Basar, I Uras, I Kiris, AT Baykal European Journal of Neuroscience 58 (4), 2985-3002, 2023 | | 2023 |
